Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 9,850 shares at $7.45 ($71K) on 2018-10-03, disclosed to the SEC on 2018-10-04.
Scheduled sale ($71k) by Senior Vice President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.19 | 3,250 | $23K | 32.7% |
| 2 | $7.27 | 5,528 | $40K | 56.3% |
| 3 | $7.26 | 972 | $7K | 9.9% |
| 4 | $7.45 | 100 | $745 | 1.0% |
| Total | $7.24 avg | 9,850 | $71K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |